Table 2. Use of lipid-lowering therapy.
High-risk(SCORE ≥5%, or receiving LLT) | Very-high-risk(SCORE ≥10%, or diabetes mellitus) | |
---|---|---|
(n = 5019) | (n = 2970) | |
Any LLT | 3278 (65.3) | 1469 (49.5) |
Statins alone | 2862 (87.3) | 1299 (88.4) |
Statins with additional non-statin LLT a | 178 (5.4) | 86 (5.9) |
Non-statin LLT a | 238 (7.3) | 84 (5.7) |
aNon-statin LLT: ezetimibe, fibrates, nicotinic acid, anion exchange resins.
LLT, lipid-lowering therapy; SCORE, Systematic Coronary Risk Evaluation.